MS pills 'could be around the corner'

Tablets being developed for multiple sclerosis (MS) have been tested, with the results being published in the latest issue of the New England Journal of Medicine.

According to new studies, the oral therapies are potentially the first of their kind to treat relapsing remitting MS and have been described to be just as effective as current drugs on the market.

Furthermore, they could be available as early as next year.

Biomedical research manager at the MS Society Dr Doug Brown said that the announcement is "great news" for people with MS and heralds a shifting tide in regards to the treatment of the condition.

He explained: "Availability of oral therapies will give people greater choice and being able to take a tablet instead of unpleasant injections will come as welcome relief. The evidence is now there and we will be working with the relevant authorities to make sure those who will benefit can get access."

The MS Society and the UK Stem Cell Foundation formally marked a new collaboration by asking for research grant applications as it is now offering joint-funding of up to £1 million.

Read about Barchester expertise in offering multiple sclerosis support.